Association between serum YKL-40 levels and patient survival imply that elevated YKL-40 may serve as a promising prognostic indicator in advanced non-small cell lung cancer (NSCLC) [54,55,56,57,58]. This evidence concerns the gene CHI3L1 and non-small cell lung carcinoma.